Bioxodes
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $6.4M
Investors
- 1
About Bioxodes
Based in Belgium, Bioxodes SA is a healthcare company focused on developing innovative therapeutic solutions for thromboinflammation, particularly in treating conditions like intracerebral hemorrhage and ischemic stroke. Bioxodes SA, founded in 2013 and headquartered in Marche-en-Famenne, Belgium, specializes in therapeutic innovations for thromboinflammatory conditions.Bioxodes focuses on innovative therapeutic solutions targeting thromboinflammation, specifically addressing conditions such as intracerebral hemorrhage (ICH) and ischemic stroke. The company's lead product, BIOX-101, is a clinical-stage therapeutic that employs a unique mechanism of action to inhibit neutrophil activation and the formation of neutrophil extracellular traps (NETs), as well as blocking coagulation factors XIa and XIIa. This dual action aims to mitigate thromboinflammatory responses without increasing the risk of bleeding.Bioxodes operates within a research-driven revenue model that involves partnerships and clinical collaborations to develop and commercialize its therapeutic candidates.3. Revenue generation is anticipated from licensing agreements with pharmaceutical firms and potential direct sales to healthcare entities following regulatory approvals. The company is advancing BIOX-101 through clinical trials, particularly a Phase 2b trial for ICH, which is expected to contribute significantly to its revenue stream upon successful commercialization.
Who invested in Bioxodes
1 investor across 1 round
See all investors in Bioxodes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 2, 2025
Amount
$6.4M
Investors
Questions about Bioxodes
Who invested in Bioxodes?
Bioxodes has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bioxodes raised?
Bioxodes has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bioxodes last raise money?
Bioxodes's most recent round on record is a Series A, in Dec 2025.
What does Bioxodes do?
Based in Belgium, Bioxodes SA is a healthcare company focused on developing innovative therapeutic solutions for thromboinflammation, particularly in treating conditions like intracerebral hemorrhage and ischemic stroke.
Where is Bioxodes headquartered?
Bioxodes is headquartered in Belgium.
Which VCs invest in companies like Bioxodes?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Bioxodes's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bioxodes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.